RSH 3.85% 2.7¢ respiri limited

Product tests & clinical results, facts please, page-21

  1. 27,133 Posts.
    lightbulb Created with Sketch. 1757
    Whether the previous version of Wheezo was tested against the spirometry which is the best for assessing chronic respiratory disease not only for asthma but COPD is irrelevant??? WOW....so Wheezo is just a management and detection of wheezing and not actual management of chronic asthma (and definitely not COPD) given wheezing doesn't mean asthma attack. I'VE GOT IT NOW.
    Last edited by AlCp: 25/10/20
 
watchlist Created with Sketch. Add RSH (ASX) to my watchlist
(20min delay)
Last
2.7¢
Change
0.001(3.85%)
Mkt cap ! $34.68M
Open High Low Value Volume
2.7¢ 2.7¢ 2.7¢ $592 21.94K

Buyers (Bids)

No. Vol. Price($)
2 121771 2.7¢
 

Sellers (Offers)

Price($) Vol. No.
2.8¢ 33330 1
View Market Depth
Last trade - 13.14pm 26/08/2024 (20 minute delay) ?
RSH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.